JP2021500874A5 - - Google Patents

Download PDF

Info

Publication number
JP2021500874A5
JP2021500874A5 JP2020519382A JP2020519382A JP2021500874A5 JP 2021500874 A5 JP2021500874 A5 JP 2021500874A5 JP 2020519382 A JP2020519382 A JP 2020519382A JP 2020519382 A JP2020519382 A JP 2020519382A JP 2021500874 A5 JP2021500874 A5 JP 2021500874A5
Authority
JP
Japan
Prior art keywords
specific binding
binding molecule
fragment
molecule according
fab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020519382A
Other languages
English (en)
Japanese (ja)
Other versions
JP7325407B2 (ja
JP2021500874A (ja
Filing date
Publication date
Priority claimed from EP17306337.1A external-priority patent/EP3466975A1/en
Application filed filed Critical
Publication of JP2021500874A publication Critical patent/JP2021500874A/ja
Publication of JP2021500874A5 publication Critical patent/JP2021500874A5/ja
Application granted granted Critical
Publication of JP7325407B2 publication Critical patent/JP7325407B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020519382A 2017-10-05 2018-10-05 ガレクチン－３タンパク質に対する特異的結合分子 Active JP7325407B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17306337.1A EP3466975A1 (en) 2017-10-05 2017-10-05 A specific binding molecule directed against galectin-3 protein
EP17306337.1 2017-10-05
PCT/EP2018/077131 WO2019068863A1 (en) 2017-10-05 2018-10-05 SPECIFIC BINDING MOLECULE DIRECTED AGAINST GALECTIN-3 PROTEIN

Publications (3)

Publication Number Publication Date
JP2021500874A JP2021500874A (ja) 2021-01-14
JP2021500874A5 true JP2021500874A5 (https=) 2021-10-28
JP7325407B2 JP7325407B2 (ja) 2023-08-14

Family

ID=60119974

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020519382A Active JP7325407B2 (ja) 2017-10-05 2018-10-05 ガレクチン－３タンパク質に対する特異的結合分子

Country Status (4)

Country Link
US (1) US11091552B2 (https=)
EP (2) EP3466975A1 (https=)
JP (1) JP7325407B2 (https=)
WO (1) WO2019068863A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
AU2019215202B2 (en) * 2018-02-01 2025-11-13 Memorial Sloan Kettering Cancer Center Antibodies to Galectin-3 and methods of use thereof
WO2020160156A2 (en) 2019-01-30 2020-08-06 Immutics, Inc. Anti-gal3 antibodies and uses thereof
EP4157338A4 (en) * 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
WO2022125482A1 (en) * 2020-12-08 2022-06-16 Memorial Sloan Kettering Cancer Center Antibodies to galectin-3 and methods of use thereof
CN115746134A (zh) * 2021-10-15 2023-03-07 深圳市睿盟创新生物科技有限公司 半乳糖凝集素-3的免疫测定
CN118524852A (zh) * 2021-11-09 2024-08-20 真和制药有限公司 治疗或抑制心血管疾病的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000007I2 (de) 1986-04-09 2010-12-30 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
WO2007137616A1 (en) 2006-05-30 2007-12-06 Millegen Highly diversified antibody libraries
WO2008112559A1 (en) * 2007-03-09 2008-09-18 Regents Of The University Of California Suppression of galectin-3 for treating an inflammatory condition
FR2919062B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal.
AU2009340423B2 (en) 2008-10-29 2014-07-24 Bg Medicine, Inc. Galectin-3 immunoassay
AR099707A1 (es) 2014-03-10 2016-08-10 La Jolla Pharma Co Composiciones y métodos para tratar trastornos renales
WO2016004093A2 (en) * 2014-07-01 2016-01-07 Stealth Biotherapeutics Corp Therapeutic compositions including galectin-3 inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
JP2021500874A5 (https=)
CN113316591A (zh) Cd73抗体及其制备方法和应用
JP2018504907A5 (https=)
JP2017176174A5 (https=)
JP2013539454A5 (https=)
JP2022502371A5 (https=)
JP2019535763A5 (https=)
CN115734972A (zh) 抗cd73抗体及其用途
CN115551888A (zh) 抗cd73抗体及其用途
JP2020501532A5 (https=)
JP2020508303A5 (https=)
JP2017048194A5 (https=)
JP2018537399A5 (https=)
MA43024B1 (fr) Anticorps humanisés cd19 antihumains et procédés d'utilisation
PE20181336A1 (es) Anticuerpos que se unen a interleucina 8 (il-8) y sus usos
CN112004801A (zh) 一种c-MET 抑制剂的晶型及其盐型和制备方法
NL300919I2 (nl) Brodalumab
WO2017184619A3 (en) Agonistic antibodies that bind human cd40 and uses thereof
JP2016063812A5 (https=)
PE20071055A1 (es) Anticuerpos anti mn
PE20181270A1 (es) Anticuerpo que neutraliza el virus respiratorio sincitial humano
JP2017113019A5 (https=)
EA201291243A1 (ru) Антитела против респираторно-синцитиального вируса (рсв) и способы их применения
JP2015527366A5 (https=)
CN113348180A (zh) Ox40抗体及其制备方法和应用